As an open access journal, The Korean Journal of Medicine (KJM) will follow the Principles of Transparency and Best Practice in Scholarly Publishing (https://doaj.org/bestpractice) developed by Committee on Publication Ethics (COPE), the Directory of Open Access Journals (DOAJ), the Open Access Scholarly Publishers Association (OASPA), and the World Association of Medical Editors (WAME).

Table of Contents

• 1. Website
• 2. Name of journal
• 3. Peer review process
• 4. Ownership and management
• 5. Governing body
• 6. Editorial team and contact information
• 7. Copyright and licensing
• 8. Author fees
• 9. Process for the identification of and dealing with allegations of research misconduct
• 10. Publication ethics
• 11. Publishing schedule
• 12. Access
• 13. Archiving
• 14. Revenue sources
• 15. Advertising
• 16. Direct marketing

1. Website

The URL of official journal web site is https://ekjm.org.

The KJM team endeavors to make a good website. KJM website demonstrates that care has been taken to ensure high ethical and professional standards. It does not contain any misleading information, including any attempt to mimic another journal/publisher’s site.

2. Name of journal

The official journal title is The Korean Journal of Medicine. Abbreviated title is Korean J Med.

3. Peer review process

Type of peer review: Single-blind review

The KJM has on online submission and peer review system at https://submit.ekjm.org.

All papers, including those invited by the Editor, are subject to peer review. A manuscript is first reviewed for its format and adherence to the aims and scope of the journal. If the manuscript does not fit the aims and scope of the Journal or does not adhere to the Instructions for Authors, it may be returned to the author immediately after receipt and without a review. Before reviewing, all submitted manuscripts are inspected by Similarity Check powered by iThenticate (https://www.crossref.org/services/similarity-check/), a plagiarism-screening tool.

The manuscripts are sent to two or more most relevant investigators for review of the contents. The editor selects peer referees by recommendation of the Editorial Board members or from the specialist database owned by the Editorial Board. The peer review process takes usually four to 8 weeks after the manuscript submission.

4. Ownership and management

The journal is owned by the publisher, the Korean Association of Internal Medicine (https://eng.kaim.or.kr).

5/6. Governing body / Editorial team and contact information

The governing body is the journal's editorial board. The full names and affiliations of the journal’s editors and members of journal management team are displayed on the About (Editorial Board tab of journal homepage, and the contact information for the Editor and editorial office is on the About (Contact us) tab.

7. Copyright and licensing

Copyright to all published materials is owned by the Korean Association of Internal Medicine. All authors should agree to the copyright transfer during the submission process.

KJM is an open access journal. Articles are distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. To use the tables or figures of KJM in other journals, books or media for scholarly, educational purposes, the process of permission request to the publisher of KJM is not necessary. All contents of the journal are available immediately upon publication without embargo period.

8. Author fees

There is no author’s submission fee or other publication-related fees as all publication costs are shouldered by the publisher.

9. Process for the identification of and dealing with allegations of research misconduct

The editorial board of KJM have carefully examined all submitted manuscripts whether these are abided by the ethical guidelines of the ICMJE and COPE. The published articles have involved the statements of conflict of interest, institutional review board, informed consent, and human/animal rights.

When the Journal faces suspected cases of research and publication misconduct such as a redundant (duplicate) publication, plagiarism, fabricated data, changes in authorship, undisclosed conflicts of interest, an ethical problem discovered with the submitted manuscript, a reviewer who has appropriated an author’s idea or data, complaints against editors, and other issues, the resolving process will follow the flowchart provided by the COPE (https://publicationethics.org/guidance/Flowcharts). The editorial board of KJM will discuss the suspected cases and reach a decision. KJM will not hesitate to publish errata, corrigenda, clarifications, retractions, and apologies when needed.

10. Publication ethics

KJM follows the Guideline on Good Publication of COPE (https://publicationethics.org), Recommendations of International Committee of Medical Journal Editors (http://www.icmje.org/recommendations), and Good Publication Practice Guidelines for Medical Journals of Korean Association of Medical Journal Editors (http://kamje.or.kr). Our publication ethics are displayed on the Editorial Policy (Publication Ethics) tab of journal homepage.

11. Publishing schedule

The Korean Journal of Medicine is published bimonthly in the first day of February, April, June, August, October and December.

12. Access

KJM is an open access journal. A free full-text service both in the XML and PDF formats is available immediately upon publication without embargo period.

13. Archiving

Full text of The Korean Journal of Medicine has been archived in National Library of Korea (http://www.nl.go.kr). According to the deposit policy (self-archiving policy) of Sherpa/Romeo (http://www.sherpa.ac.uk), authors cannot archive pre-print (i.e., pre-refereeing), but they can archive post-print (i.e., final draft post-refereeing). Authors can archive publisher's version/PDF.

14. Revenues sources

Revenue sources of journal are from the support of publisher (Korean Association of Internal Medicine).

15. Advertising

We accept advertising and sponsorship for its printed journal according to the following principles:

- Advertising is separate from content. Advertisers and sponsors have no advance knowledge of our editorial contents, nor do the editors have advance knowledge of advertisers. Content is never altered, added, or deleted to accommodate advertising. Advertisers and sponsors have no input regarding any of our editorial decisions or advertising policies.
- We reserve the right to decline or cancel any advertisement at any time.
- Advertisements for pharmaceutical products must conform to all regulations and policies of the Ministry of Food and Drug Safety, Republic of Korea in every respect.

16. Direct marketing

Journal propagation has been done through the journal web site and distribution of an introduction pamphlet. Invitations to submit a manuscript are usually focused on the presenters at conferences, seminars, or workshops if the topic is related to the journal's aims and scope.